Cargando…

Amomum subulatum: A treasure trove of anti-cancer compounds targeting TP53 protein using in vitro and in silico techniques

Cancer is a primary global health concern, and researchers seek innovative approaches to combat the disease. Clinical bioinformatics and high-throughput proteomics technologies provide powerful tools to explore cancer biology. Medicinal plants are considered effective therapeutic agents, and compute...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Sadaqat, Noreen, Asifa, Qamar, Adeem, Zafar, Imran, Ain, Quratul, Nafidi, Hiba-Allah, Bin Jardan, Yousef A., Bourhia, Mohammed, Rashid, Summya, Sharma, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189520/
https://www.ncbi.nlm.nih.gov/pubmed/37206196
http://dx.doi.org/10.3389/fchem.2023.1174363
_version_ 1785043105769062400
author Ali, Sadaqat
Noreen, Asifa
Qamar, Adeem
Zafar, Imran
Ain, Quratul
Nafidi, Hiba-Allah
Bin Jardan, Yousef A.
Bourhia, Mohammed
Rashid, Summya
Sharma, Rohit
author_facet Ali, Sadaqat
Noreen, Asifa
Qamar, Adeem
Zafar, Imran
Ain, Quratul
Nafidi, Hiba-Allah
Bin Jardan, Yousef A.
Bourhia, Mohammed
Rashid, Summya
Sharma, Rohit
author_sort Ali, Sadaqat
collection PubMed
description Cancer is a primary global health concern, and researchers seek innovative approaches to combat the disease. Clinical bioinformatics and high-throughput proteomics technologies provide powerful tools to explore cancer biology. Medicinal plants are considered effective therapeutic agents, and computer-aided drug design (CAAD) is used to identify novel drug candidates from plant extracts. The tumour suppressor protein TP53 is an attractive target for drug development, given its crucial role in cancer pathogenesis. This study used a dried extract of Amomum subulatum seeds to identify phytocompounds targeting TP53 in cancer. We apply qualitative tests to determine its phytochemicals (Alkaloid, Tannin, Saponin, Phlobatinin, and Cardic glycoside), and found that alkaloid composed of 9.4% ± 0.04% and Saponin 1.9% ± 0.05% crude chemical constituent. In the results of DPPH Analysis Amomum subulatum Seeds founded antioxidant activity, and then we verified via observing methanol extract (79.82%), BHT (81.73%), and n-hexane extract (51.31%) found to be positive. For Inhibition of oxidation, we observe BHT is 90.25%, and Methanol (83.42%) has the most significant proportion of linoleic acid oxidation suppression. We used diverse bioinformatics approaches to evaluate the effect of A. subulatum seeds and their natural components on TP53. Compound-1 had the best pharmacophore match value (53.92), with others ranging from 50.75 to 53.92. Our docking result shows the top three natural compounds had the highest binding energies (−11.10 to −10.3 kcal/mol). The highest binding energies (−10.9 to −9.2 kcal/mol) compound bonded to significant sections in the target protein’s active domains with TP53. Based on virtual screening, we select top phytocompounds for targets which highly fit based on pharmacophore score and observe these compounds exhibited potent antioxidant activity and inhibited cancer cell inflammation in the TP53 pathway. Molecular Dynamics (MD) simulations indicated that the ligand was bound to the protein with some significant conformational changes in the protein structure. This study provides novel insights into the development of innovative drugs for the treatment of cancer disorders.
format Online
Article
Text
id pubmed-10189520
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101895202023-05-18 Amomum subulatum: A treasure trove of anti-cancer compounds targeting TP53 protein using in vitro and in silico techniques Ali, Sadaqat Noreen, Asifa Qamar, Adeem Zafar, Imran Ain, Quratul Nafidi, Hiba-Allah Bin Jardan, Yousef A. Bourhia, Mohammed Rashid, Summya Sharma, Rohit Front Chem Chemistry Cancer is a primary global health concern, and researchers seek innovative approaches to combat the disease. Clinical bioinformatics and high-throughput proteomics technologies provide powerful tools to explore cancer biology. Medicinal plants are considered effective therapeutic agents, and computer-aided drug design (CAAD) is used to identify novel drug candidates from plant extracts. The tumour suppressor protein TP53 is an attractive target for drug development, given its crucial role in cancer pathogenesis. This study used a dried extract of Amomum subulatum seeds to identify phytocompounds targeting TP53 in cancer. We apply qualitative tests to determine its phytochemicals (Alkaloid, Tannin, Saponin, Phlobatinin, and Cardic glycoside), and found that alkaloid composed of 9.4% ± 0.04% and Saponin 1.9% ± 0.05% crude chemical constituent. In the results of DPPH Analysis Amomum subulatum Seeds founded antioxidant activity, and then we verified via observing methanol extract (79.82%), BHT (81.73%), and n-hexane extract (51.31%) found to be positive. For Inhibition of oxidation, we observe BHT is 90.25%, and Methanol (83.42%) has the most significant proportion of linoleic acid oxidation suppression. We used diverse bioinformatics approaches to evaluate the effect of A. subulatum seeds and their natural components on TP53. Compound-1 had the best pharmacophore match value (53.92), with others ranging from 50.75 to 53.92. Our docking result shows the top three natural compounds had the highest binding energies (−11.10 to −10.3 kcal/mol). The highest binding energies (−10.9 to −9.2 kcal/mol) compound bonded to significant sections in the target protein’s active domains with TP53. Based on virtual screening, we select top phytocompounds for targets which highly fit based on pharmacophore score and observe these compounds exhibited potent antioxidant activity and inhibited cancer cell inflammation in the TP53 pathway. Molecular Dynamics (MD) simulations indicated that the ligand was bound to the protein with some significant conformational changes in the protein structure. This study provides novel insights into the development of innovative drugs for the treatment of cancer disorders. Frontiers Media S.A. 2023-04-26 /pmc/articles/PMC10189520/ /pubmed/37206196 http://dx.doi.org/10.3389/fchem.2023.1174363 Text en Copyright © 2023 Ali, Noreen, Qamar, Zafar, Ain, Nafidi, Bin Jardan, Bourhia, Rashid and Sharma. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Ali, Sadaqat
Noreen, Asifa
Qamar, Adeem
Zafar, Imran
Ain, Quratul
Nafidi, Hiba-Allah
Bin Jardan, Yousef A.
Bourhia, Mohammed
Rashid, Summya
Sharma, Rohit
Amomum subulatum: A treasure trove of anti-cancer compounds targeting TP53 protein using in vitro and in silico techniques
title Amomum subulatum: A treasure trove of anti-cancer compounds targeting TP53 protein using in vitro and in silico techniques
title_full Amomum subulatum: A treasure trove of anti-cancer compounds targeting TP53 protein using in vitro and in silico techniques
title_fullStr Amomum subulatum: A treasure trove of anti-cancer compounds targeting TP53 protein using in vitro and in silico techniques
title_full_unstemmed Amomum subulatum: A treasure trove of anti-cancer compounds targeting TP53 protein using in vitro and in silico techniques
title_short Amomum subulatum: A treasure trove of anti-cancer compounds targeting TP53 protein using in vitro and in silico techniques
title_sort amomum subulatum: a treasure trove of anti-cancer compounds targeting tp53 protein using in vitro and in silico techniques
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189520/
https://www.ncbi.nlm.nih.gov/pubmed/37206196
http://dx.doi.org/10.3389/fchem.2023.1174363
work_keys_str_mv AT alisadaqat amomumsubulatumatreasuretroveofanticancercompoundstargetingtp53proteinusinginvitroandinsilicotechniques
AT noreenasifa amomumsubulatumatreasuretroveofanticancercompoundstargetingtp53proteinusinginvitroandinsilicotechniques
AT qamaradeem amomumsubulatumatreasuretroveofanticancercompoundstargetingtp53proteinusinginvitroandinsilicotechniques
AT zafarimran amomumsubulatumatreasuretroveofanticancercompoundstargetingtp53proteinusinginvitroandinsilicotechniques
AT ainquratul amomumsubulatumatreasuretroveofanticancercompoundstargetingtp53proteinusinginvitroandinsilicotechniques
AT nafidihibaallah amomumsubulatumatreasuretroveofanticancercompoundstargetingtp53proteinusinginvitroandinsilicotechniques
AT binjardanyousefa amomumsubulatumatreasuretroveofanticancercompoundstargetingtp53proteinusinginvitroandinsilicotechniques
AT bourhiamohammed amomumsubulatumatreasuretroveofanticancercompoundstargetingtp53proteinusinginvitroandinsilicotechniques
AT rashidsummya amomumsubulatumatreasuretroveofanticancercompoundstargetingtp53proteinusinginvitroandinsilicotechniques
AT sharmarohit amomumsubulatumatreasuretroveofanticancercompoundstargetingtp53proteinusinginvitroandinsilicotechniques